Malladi Drugs & Pharmaceuticals, Ltd. v. TandyMalladi Drugs & Pharmaceuticals, Ltd. v. Tandy
Opinion for the Court filed by Chief Judge SENTELLE.
Malladi Drugs and Pharmaceuticals, Ltd. and Novus Fine Chemicals, LLC (collectively, “Malladi”) sued the federal Drug Enforcement Administration (“DEA”) for the return of $1,420,000 worth of ephed-
I
The forfeited chemicals at the center of this dispute are List I chemicals used in the manufacture of controlled substances, which generally are either illegal drugs or drugs available only by prescription.
See
The сustoms laws, as modified by the Civil Asset Forfeiture Reform Act of 2000,
Once notified, interested parties mаy choose to allow the forfeiture to proceed administratively or may compel the government to initiate a judicial forfeiture action by filing a claim for the property.
If no interested party files a claim, then the DEA administratively forfeits the property by default and the only option remaining for an interested party is to file a petition for remission or mitigation of the
II
Malladi Drugs and Pharmaceuticals, Ltd. (“Malladi DPL”), a corporation based in India, is a supplier of pharmaceutical raw materials. At the time of the underlying events, Malladi, Inc., a United States subsidiary of Malladi DPL, imported List I chemicals from Malladi DPL and sold them in the United States to Novus Fine Chemicals, LLC (“Novus”), amоng other companies. Novus is now a wholly-owned subsidiary of Malladi DPL, and Malladi, Inc., which is not a party to this litigation, has ceased operations.
On April 6, 2005, DEA agents inspected Malladi, Inc.’s record-keeping procedures for List I chemicals at its corporate headquarters in New Jersey. The agents “expressed reservations” about the organization of Malladi, Inc.’s file room, its document retention system, and the availability of documentation necessary to reconcile inventory. The DEA agents returned to Malladi, Inc.’s headquarters two days later and seized 233 drums of ephedrine and pseudoephedrine in inventory, valued at $241,500. On April 11, the agents again returned to Malladi, Inc.’s corporate headquarters and, according to the allegations of the complaint, demanded surrender of the company’s DEA import registration, which the manager relinquished “under duress and pressure from several DEA officials.” After Malladi, Inc. surrendered its import registration, the DEA seized three shipments of ephedrine and pseudoephedrine shipped from Malladi DPL in India to Malladi, Inc. in New Jersey upon their arrival at United States ports: 400 drums of ephedrine hydrochloride, valued at $464,000, on April 14; 240 drums of pseu-doephedrine hydrochloride, valued at $250,500, on April 27; and 400 drums of ephedrine hydrochloride, valued at $464,000, on May 2. The aggregate value of all four seizures from Malladi, Inc. was $1,420,000.
The DEA notified Malladi, Inc. of the four seizures and its intention to administratively forfeit the chemicals. The letters of notification also informed Malladi, Inc. of the procedures and deadlines for filing a claim to contest the forfeiture in court and for filing a petition requesting remission or mitigation of the forfeiture from the DEA. Malladi did not file a claim for the property, which would have entitled it to judicial forfeiture proceedings, but instead allowed the DEA to administratively forfeit the goods and then filed a petition for remission of each of the four seizures. The DEA denied all four petitions and administratively forfeited the chemicals.
Malladi then filed suit against the DEA in district court for return of the chemicals or the institution of judicial forfeiture proceedings. In its action, Malladi contеnded that the DEA was required to pursue judicial, rather than administrative, forfeiture because the four seizures — the aggregated value of which exceeded $500,000 — were part of a single plan accomplished when the DEA seized Malladi’s inventory and then “constructively seized” the three inbound shipments by demanding Malladi’s import registration.
See
Malladi appealed and now argues that the district court failed to aсcept the facts alleged in the complaint in the light most favorable to Malladi when the court rejected the factual allegation of duress because it believed that allegation contradicted Malladi’s explanation in its petitions to the DEA that it voluntarily surrendered its import registration. We affirm the district court’s dismissal of the complaint, but on thе alternative ground that Malladi failed to exhaust its administrative remedies before the DEA and should not now be given a second opportunity to pursue judicial forfeiture when it failed to seek that remedy within the statutory deadline.
Ill
We review
de novo
the district court’s granting of the motion to dismiss and we may affirm the judgment of that court on grounds different from those assigned in the decision under reviеw.
Danielsen v. Burnside-Ott Aviation Training Ctr., Inc.,
The statutes and regulations governing DEA forfeiture of List I chemicals set forth only two options for a party asserting ownership to contest an administrative forfeiture and reclaim its property: a petition for remission, which asks the agency for discretionary return of the property, and a claim, which initiates the judicial process to decide whether the property should be forfeited. A party claiming ownership of the seized property may choose to pursue either the administrative or the legal remedy, complying with the applicable filing deadline for its choice.
1
As previously discussed, if no one files a сlaim for the property, the DEA may administratively forfeit it by default, which forfeiture has the same force and effect as a final decree and order of forfeiture in a judicial proceeding. This administrative system efficiently settles disputes over property
Malladi received from the DEA four notices of seizure and intent to administratively forfeit the seized chemicals, and each notice informed Malladi of the procedures and deadlines for filing a claim to contest the forfeiture in court and for filing a petition requesting remission or mitigation of the forfeiture. The notices further alerted Malladi that failure to file a claim contesting the forfeiture and seeking judicial resolution would “result in the termination of [its] interest in the asset, and may preclude ... contesting the forfeiture of the asset in any judicial proceeding.” Malladi chose not to file a claim contesting any of the four administrative forfeitures or to pursue the judicial forfeiture route in аny way. Instead, Malladi chose only to pursue the discretionary petition route and allowed the June and July 2005 deadlines for filing a claim to pass. Its chosen remedy having failed, Malladi now for the first time seeks the alternative remedy of judicial forfeiture, outside the statutorily-provided administrative procedures and deadlines.
The forfeiture statutes and regulations provide alternative, not sequential, administrative and legal remedies for an administrative forfeiture. Malladi elected to forego the legal remedy it seeks here when it chose the discretionary administrative remedy and allowed the time for filing a claim under the administrative scheme to pass. Having waived its opportunity for judicial forfеiture proceedings during the administrative process, Malladi may not now attempt to correct its choice of remedy in federal court.
See Cole v. United States (In re $844,520),
Malladi compounded the exhaustion problem by failing to raise its argument about aggregation and judicial forfeiture before the DEA at all, even in the petitions that it did file. For the first time, Malladi now argues that the DEA should hаve initiated judicial forfeiture proceedings without the stimulus of a claim, based on the aggregated value of the seized proper
Aggregation of drug seizures, thus, is just the sort of open and fact-specific question that agency expertise is best suited to consider in the first instance, highlighting exhaustion’s “twin purposes of protecting administrative agency authority and promoting judicial efficiency.”
Ass’n of Flight Attendants,
Malladi urges that because this action is a collateral attack on the administrative forfeiture rather than a direct appeal from an agency decision, it may raise new arguments that it did not assert before the agency. The critical distinction, however, is not the рosture of the complaint but rather whether the plaintiff had the opportunity to call the alleged error to the agency’s attention in the prior proceedings. If, for example, inadequate notice or illegal procedures prevented the plaintiff from being able to raise its objection before the agency, courts may allоw the plaintiff to raise the objection for the first time in a collateral attack on the agency action.
See Sarit,
For the foregoing reasons, we affirm the district court’s dismissal of the complaint on the alternative ground that Malladi has failed tо exhaust its administrative remedies.
Notes
. The DEA’s notice-of-seizure form states that a party claiming ownership “may petition the DEA for return of the properly ... and/or ... may contest the seizure and forfeiture of the properly in Federal court,’’ implying that an owner may pursue both routes. This may be true, but as a practical matter, filing a claim to contest the forfeiture in court ends the administrative forfeiture from which an owner would petition for remission.